Vest Financial LLC Grows Stake in Chemed Corporation $CHE

Vest Financial LLC boosted its position in shares of Chemed Corporation (NYSE:CHE) by 68.7% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,319 shares of the company’s stock after purchasing an additional 2,981 shares during the quarter. Vest Financial LLC owned about 0.05% of Chemed worth $3,564,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Renasant Bank increased its holdings in shares of Chemed by 2.3% in the 1st quarter. Renasant Bank now owns 815 shares of the company’s stock valued at $501,000 after acquiring an additional 18 shares during the period. Cim LLC increased its holdings in shares of Chemed by 1.0% in the 1st quarter. Cim LLC now owns 2,029 shares of the company’s stock valued at $1,248,000 after acquiring an additional 21 shares during the period. First Horizon Advisors Inc. increased its holdings in shares of Chemed by 16.1% in the 1st quarter. First Horizon Advisors Inc. now owns 173 shares of the company’s stock valued at $107,000 after acquiring an additional 24 shares during the period. Cynosure Group LLC increased its holdings in shares of Chemed by 4.3% in the 1st quarter. Cynosure Group LLC now owns 581 shares of the company’s stock valued at $358,000 after acquiring an additional 24 shares during the period. Finally, Farther Finance Advisors LLC increased its holdings in shares of Chemed by 23.0% in the 1st quarter. Farther Finance Advisors LLC now owns 150 shares of the company’s stock valued at $93,000 after acquiring an additional 28 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Stock Performance

Shares of CHE opened at $429.20 on Tuesday. The stock has a 50-day moving average of $448.56 and a two-hundred day moving average of $507.92. Chemed Corporation has a one year low of $408.42 and a one year high of $623.60. The stock has a market cap of $6.25 billion, a P/E ratio of 22.07, a P/E/G ratio of 2.50 and a beta of 0.43.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing analysts’ consensus estimates of $6.02 by ($1.75). Chemed had a return on equity of 25.83% and a net margin of 11.56%.The firm had revenue of $618.80 million for the quarter, compared to analyst estimates of $650.60 million. During the same period in the prior year, the firm posted $5.47 EPS. The business’s revenue was up 3.8% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Analysts predict that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were issued a $0.60 dividend. This is a boost from Chemed’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Monday, August 11th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s payout ratio is presently 12.34%.

Insider Buying and Selling

In other news, Director Patrick P. Grace sold 150 shares of the business’s stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $463.39, for a total value of $69,508.50. Following the completion of the transaction, the director owned 3,397 shares of the company’s stock, valued at $1,574,135.83. The trade was a 4.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director George J. Walsh III purchased 200 shares of the business’s stock in a transaction that occurred on Monday, August 4th. The stock was acquired at an average price of $417.10 per share, with a total value of $83,420.00. Following the purchase, the director owned 3,523 shares in the company, valued at $1,469,443.30. This represents a 6.02% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders sold 13,162 shares of company stock worth $5,677,511. Corporate insiders own 3.29% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CHE. Oppenheimer cut their price target on Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a report on Thursday, July 31st. Jefferies Financial Group upgraded Chemed from a “hold” rating to a “buy” rating and lifted their price target for the company from $490.00 to $550.00 in a report on Tuesday, September 2nd. Bank of America lowered their price objective on Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Finally, Royal Bank Of Canada lowered their price objective on Chemed from $640.00 to $589.00 and set an “outperform” rating for the company in a research report on Thursday, July 31st. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $578.50.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.